On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...

Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Boston Scientific Obsidio Embolic device Boston Scientific updated its instructions Oct. 18 for its Obsidio conformable embolic device, following reports of 15 serious injuries and four deaths ...

(File photo: CNA/Raydza Rahman) SINGAPORE: The Ministry of Education (MOE) will roll out new device management applications to students’ Chromebooks and iPads from November 2024 and January 2025 ...

Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Call Transcript October 23, 2024 Boston Scientific Corporation ...

in listen only mode. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to John Munson, Senior Vice President, Investor Relations. Please ...

Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www ...

“Globally, we surpassed 500,000 patients treated with a Watchman device driven by our innovation, clinical evidence and patient-awareness efforts,” Mahoney said. Boston Scientific’s business ...

Marlborough-based Boston Scientific increased its estimated net sales growth for 2024. Meanwhile, Thermo Fisher slightly raised its full-year adjusted earnings per share guidance. Boston ...

Erica Denhoff / Icon Sportswire via Getty Images Boston Scientific shares fell Wednesday as its third-quarter profit missed estimates. The medical device maker's adjusted earnings per share and ...